Please sign in first
Not a member?
TRANSLATIONAL PARKINSON’S DISEASE RESEARCH
Research in Patrik Brundin’s laboratory focuses on pathogenetic mechanisms and pharmacological treatment in cell and animal models of Parkinson’s disease. The group’s mission is to understand neurodegenerative diseases and develop new therapies that are of benefit
to patients and their caregivers.
NEWS
In the Press
22 March 2019 Patrik Brundin: life on the river
Adrian Burton | The Lancet
9 Oct. 2018 Linked Clinical Trials initiative boosts number of Parkinson’s clinical studies
Jose Marques Lopes, Ph.D | Parkinson’s News Today
26 Oct. 2016 Pathology: The prion principle
Nature
2 June 2015 Dutch king and queen visit children’s hospital, learn about Parkinson’s research
MLive
29 May 2015 Dutch program could make Grand Rapids a destination for Parkinson’s care
MLive
Read More
12 Nov. 2014 Latest advances in neurodegenerative disease research focus of VAI program
MLive
24 Sept. 2014 New Parkinson’s research initiative launched by Van Andel Institute and patient advocacy group
MLive
20 August 2014 Parkinson’s research: Patient-centered meeting part of symposium bringing together global experts
MLive
17 Sept. 2013 Parkinson’s symposium honors doctor who developed deep brain stimulation treatment
MLive
20 August 2013 VAI protein research could “slow the progression” of Parkinson’s
Grand Rapids Business Journal
15 Nov. 2012 Gangs of corrupted proteins spread through mouse brains and cause Parkinson’s-like symptoms
Discover
27 June 2012 Closing in on a Parkinson’s drug: Van Andel scientist hopes study will lead way to halt disease
MLive
30 May 2012 First treatment for Huntington’s disease shows promise in rats, Van Andel Institute scientists say
MLive
27 Oct. 2011 For Van Andel Institute’s new lead scientist in Parkinson’s research, fight against disease is personal
MLive
5 Oct. 2011 Clumps of rogue Parkinson’s proteins spread to new neurons and seed more clumps
Discover
